Table 1. Antiviral activity of Spirulina extract against influenza virus strains in vitro.
EC50 (mg/mL) | CC50 (mg/mL) | SI | |
---|---|---|---|
A/WSN/33(H1N1) | 1.17 ± 0.09 | 23.80 | 20.34 |
A/TW/3446/2002(H3N2) | 0.98 ± 0.24 | 23.80 | 24.28 |
B/TW/70555/2005 | 1.33 ± 0.15 | 23.80 | 17.89 |
A/TW/70058/2009(H1N1)* | 1.17 ± 0.08 | 23.80 | 20.34 |
A/TW/147/2009(H1N1)* | 0.98 ± 0.10 | 23.80 | 24.28 |
A/TW/126/2009(H1N1) | 0.58 ± 0.02 | 23.80 | 41.03 |
EC50: 50% effective concentration, based on the inhibition of viral plaque formation.
CC50: 50% cytotoxic concentration, based on the MTT assay.
SI: selectivity index, a ratio of CC50 to EC50.
*Oseltamivir-resistant influenza strains.
All data represent mean ± SD for three independent experiments.